BOULDER, Colo., March 8, 2007 (PRIME NEWSWIRE) -- Pharmion Corporation (Nasdaq:PHRM) today announced that Erle Mast, the Company's executive vice president and chief financial officer, will present a corporate overview at the Cowen and Company 27th Annual Health Care Conference in Boston.
The presentation will take place at 4:00 p.m. (Eastern) on Tuesday, March 13, 2007 at the Boston Marriott Copley Place in Boston, Massachusetts.
There will be a live webcast of the presentation from the conference. The webcast will be available through a link posted on the investor relations section of the Pharmion website at http://investor.pharmion.com. The webcast will be available for replay on Pharmion's website until at least April 30, 2007. The presentation will also be available to download as a podcast.
About Pharmion
Pharmion is a biopharmaceutical company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international markets. Pharmion has a number of products on the market including the world's first approved epigenetic drug, Vidaza(r), a DNA demethylating agent. For additional information about Pharmion, please visit the company's website at www.pharmion.com.